HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma.

AbstractBACKGROUND:
Interaction between tumor cells and endothelium plays a major role in cancer invasion and metastasis. Among various cell adhesion molecules, the cognate interaction between sialyl Lewis antigen expressed in the tumor cell surface and E-selectin expressed on endothelial cells is considered to be crucial for the tumor cell adhesion to the endothelium.
METHODS:
The sialyl Lewis X (sL(X)) expression in 45 specimens from renal cell carcinoma patients was examined using immunohistochemistry.
RESULTS:
In this study, we demonstrate that the immunoreactivity for sL(X) in renal cell carcinoma specimens not only correlates with conventional histopathologic parameters but also serves as a useful indicator for the prognosis of renal cell carcinoma.
CONCLUSION:
Since beneficial effect of cimetidine has been reported and ascribed to its inhibitory action on the expression of E-selectin, a ligand molecule of sialyl Lewis antigen, cimetidine may also show inhibitory effect on the tumor recurrence and metastasis of renal cell carcinoma with high level of sL(X) expression.
AuthorsKeiichi Tozawa, Takashi Okamoto, Noriyasu Kawai, Yoshihiro Hashimoto, Yutaro Hayashi, Kenjiro Kohri
JournalKidney international (Kidney Int) Vol. 67 Issue 4 Pg. 1391-6 (Apr 2005) ISSN: 0085-2538 [Print] United States
PMID15780091 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Lewis Blood Group Antigens
  • Oligosaccharides
  • Sialyl Lewis X Antigen
  • Cimetidine
Topics
  • Adjuvants, Immunologic (therapeutic use)
  • Carcinoma, Renal Cell (pathology)
  • Cimetidine (therapeutic use)
  • Humans
  • Immunohistochemistry
  • Kidney Neoplasms (pathology)
  • Lewis Blood Group Antigens
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Oligosaccharides (analysis)
  • Sialyl Lewis X Antigen

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: